Hanmi Pharm. Co., Ltd. (KRX:128940)
South Korea · Delayed Price · Currency is KRW 560,000
+41,000 (7.90%)
At close: Mar 20, 2026
Hanmi Pharm. Market Cap
Hanmi Pharm. has a market cap or net worth of 7.1 trillion as of March 20, 2026. Its market cap has increased by 108.57% in one year.
Market Cap
7.10T
Enterprise Value
7.47T
Revenue
1.47T
Ranking
n/a
PE Ratio
60.96
Stock Price
560,000.00
Market Cap Chart
Since July 30, 2010, Hanmi Pharm.'s market cap has increased from 680.70B to 7.10T, an increase of 943.18%. That is a compound annual growth rate of 16.16%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 20, 2026 | 7.10T | 23.89% |
| Dec 30, 2025 | 5.73T | 61.14% |
| Dec 30, 2024 | 3.56T | -20.49% |
| Dec 28, 2023 | 4.47T | 20.54% |
| Dec 29, 2022 | 3.71T | 10.00% |
| Dec 30, 2021 | 3.37T | -23.27% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Yuhan | 7.39T |
| Hanall Biopharma | 2.85T |
| Celltrion Pharm | 2.66T |
| Daewoong Pharmaceutical | 1.90T |
| GC Biopharma | 1.69T |
| Chong Kun Dang Pharmaceutical | 1.17T |
| Ildong Pharmaceutical | 1.03T |
| Daewoong | 989.56B |